BG
ONC

BlackRock Group’s BeOne Medicines Ltd ONC Stock Holding History

BlackRock Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$131K Buy
+4,300
New +$135K ﹤0.01% 2772
2016
Q2 		– Sell
-362
Closed -$11K – 3054
2016
Q1 		$11K Buy
+362
New +$10.3K ﹤0.01% 3034

Other funds holding ONC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

BlackRock Group's ONC Position: Q4 2016 in Review

BlackRock Group opened a new position in BeOne Medicines Ltd (ONC) in Q4 2016: 4,300 shares worth $131K. The stake represents ﹤0.01% of the portfolio and ranks #2772 among its holdings. This is a return to the name: BlackRock Group previously reported a position in ONC as recently as Q1 2016.

BlackRock Group first reported a position in ONC in Q1 2016 and has held it in 2 quarters since. 54 funds tracked by Wall St. Rank hold ONC as of Q4 2016.

  • BlackRock Group held 4,300 shares of BeOne Medicines Ltd worth $131K as of Q4 2016.
  • BeOne Medicines Ltd was a new BlackRock Group position in Q4 2016.
  • BeOne Medicines Ltd made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2772 holding.
  • BlackRock Group first reported a position in BeOne Medicines Ltd in Q1 2016 and has held it in 2 quarters since.
  • 54 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.